Immunoprecipitation:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Control:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Software:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Expressing:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Generated:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
SDS Page:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Western Blot:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Purification:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Recombinant:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Incubation:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Molecular Weight:Article Title: Syntaxin 4-enhanced plasma membrane repair is independent of dysferlin in skeletal muscle
Article Snippet: Antibodies used are as follows: anti-troponin I (TnI, 1:500; MAB1691, Millipore), anti-dysferlin (DYSF, 1:100; ab124684, Abcam), anti-syntaxin4 (STX4, 1:250; 110042, Synaptic Systems), anti-synaptosome-associated protein 23 (SNAP23, 1:200; ab4114, Abcam), anti-synaptosome-associated protein 25 (SNAP25, 1:100; NBP1–33714, Novus Biologicals), anti-vesicle-associated membrane protein 2 (VAMP2, 1:100; NBP3–13179, Novus Biologicals), Alexa 488-conjugated goat anti-mouse IgG (1:400; 115–546-062, Jackson ImmunoResearch), Alexa 647-conjugated donkey anti-rabbit IgG (1:400; 711–605-152, Jackson ImmunoResearch).
Article Title: Cardiac SNARE Expression in Health and Disease
Article Snippet: Anti-VAMP1 (#104002), anti-VAMP2 (#104202), anti-VAMP3 (#43080), anti-VAMP4 (#136002), anti-VAMP5 (#176003), anti-VAMP7 (#232003), anti-VAMP8 (#104302), anti-SNAP23 (#111202), anti-SNAP29 (#111303), anti-SNAP47 (#111403), anti-syntaxin2 (#110022), anti-syntaxin3 (#110032), anti-syntaxin4 (#110042), anti-syntaxin5 (#110053), anti-syntaxin7 (#110072), anti-syntaxin8 (#110083), and anti-syntaxin16 (#110162) were from Synaptic Systems (Goettingen, Germany).
Article Title: SNARE ‐binding protein synaptosomal‐associated protein of 29 kDa (SNAP29) regulates the intracellular sequestration of glucose transporter 4 (GLUT4) vesicles in adipocytes
Article Snippet: The following antibodies were used: anti‐GLUT4, anti‐GFP, anti‐GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti‐HA (HA‐7; Sigma Aldrich, St. Louis, MO, USA); anti‐SNAP29, anti‐syntaxin4, anti‐syntaxin6 (Synaptic Systems, Gottingen, Germany); anti‐phospho‐Akt (Ser473), anti‐Akt (pan; Cell Signaling Technology, Danvers, MA, USA); and secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
|